[Federal Register Volume 64, Number 158 (Tuesday, August 17, 1999)]
[Notices]
[Page 44738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21263]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Intervention Research Addressing the Primary and 
Secondary Prevention Needs of HIV-Seropositive Injection Drug Users

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: Intervention Research Addressing the Primary 
and Secondary Prevention Needs of HIV-Seropositive Injection Drug 
Users, Program Announcement #99090.
    Times and Dates: 8:30 a.m.-9:00 a.m., August 26, 1999 (Open); 
9:00 a.m.-4:30 p.m., August 26, 1999 (Closed).
    Place: CDC, National Center for HIV, STD and TB Prevention, 
Executive Park, Building 57, Fifth Floor Conference Room, Atlanta, 
GA 30329.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement #99090.
    Contact Person for More Information: Beth Wolfe, Prevention 
Support Office, National Center for HIV, STD, and TB Prevention, 
CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail 
EOW[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for the both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

    Dated: August 9, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-21263 Filed 8-12-99; 1:42 pm]
BILLING CODE 4163-18-P